What Is Ginseng - Panax? Benefits, Harms and Use in Cancer

In this article
What Is Ginseng?
Named after the Greek expression healing everything represented by Panacea, ginseng (Panax) has occupied an important place in Chinese Medicine for many years. As its name suggests, it is believed to be a miraculous plant effective against many health problems. It is claimed to have numerous properties, including calming, aphrodisiac, antidepressant, diuretic and immune system stimulating effects; it is claimed to be effective in treating health problems such as diabetes, Alzheimer's disease, erectile dysfunction (erection problems) and infections. In recent years, its purported effects in preventing and treating cancer and reducing cancer-related complaints have also been emphasized. However, studies do not confirm these effects. Although some studies of its effects on colds, diabetes, Alzheimer's disease and erectile dysfunction have produced positive results, it is too early to say anything definitive. In cancer patients, it has only been shown to be effective in reducing fatigue associated with cancer and cancer treatment. Although ginseng is considered a relatively safe product, it can cause significant drug interactions. At present, it therefore seems reasonable to use ginseng in cancer patients only for cancer-related fatigue. However, this must always be done with oncologists' knowledge and supervision.
What Are Its Characteristics?
The botanical name, Panax, comes from Panacea, meaning “healing everything” in Greek. The plant's English name, ginseng, originates from the Chinese word renshen. Because its forked roots resemble human legs, the Chinese words “ren,” meaning human, and “shen,” meaning plant root, were used. Although seven ginseng species are distributed across Asia and North America, there are primarily two main types with medicinal properties that have been studied: the Latin name panax ginseng refers to Asian (Chinese or Korean) ginseng and Panax quinquefolius, American ginseng. Asian is also called red ginseng. Both contain ginsenosides, but differing contents lead traditional Chinese medicine to call Asian ginseng warming (yang) and American cooling (yin).
American and Asian ginseng, claimed to be effective for many health problems, have become particularly popular in recent years. Ginseng products, whose consumption is increasingly widespread, are manufactured and marketed in many forms. Products are available as powders, capsules, tablets, soft gels, liquid extracts, tea and coffee. Some energy drinks even include ginseng.
For many years, American and Asian ginseng have been tested in numerous studies for many health problems. The literature contains many studies of effects such as calming, aphrodisiac, nervous-system stimulating, antidepressant and diuretic activity. Effects on physical performance, psychomotor performance and HSV-2 infection have also been investigated. Ultimately, however, its effectiveness in any of these conditions has not progressed beyond reasonable doubt. A few studies also report effectiveness in treating erectile dysfunction, but they are insufficient to draw conclusions. Evidence relating to the immune system, cognitive performance and blood sugar control is relatively stronger but remains unconfirmed. A small study involving 19 people suggested that American ginseng might help prevent low blood sugar after meals. A study assessing long-term safety as an adjunct to standard treatment in diabetic patients found no significant difference in side effects. A study of American ginseng's immune-supporting properties involving 279 people found fewer colds among those taking it for 4 months at 2 capsules a day compared with those not taking it. A preliminary study involving few patients also found that American ginseng improved memory performance. Another study observed improved cognitive performance in Alzheimer's patients with Asian ginseng.
Cancer claims have attracted attention, but strong evidence for prevention or treatment is absent. Benefits have been demonstrated for fatigue from cancer and treatment.
Does It Prevent or Treat Cancer?
Claims about ginseng's effects in cancer prevention and treatment are based primarily on laboratory studies. The few clinical studies performed have not produced strong evidence for these effects. The American health institute also states that there is insufficient evidence that ginseng is effective in preventing and treating cancer.
In a laboratory study, American ginseng extract inhibited cell growth in colorectal cancer cell lines; this effect was greater when combined with the chemotherapy drug 5-fluorouracil (5-FU). It was therefore suggested that American ginseng might reduce the required 5-FU dose in the future. Another laboratory study found that American ginseng extract inhibited cell proliferation in breast cancer cell lines. In another study of breast cancer cell cultures, American ginseng inhibited cell growth alongside the chemotherapy drugs methotrexate, cyclophosphamide, doxorubicin and 5-fluorouracil. Yet another study found that American ginseng extract triggered cell death in colorectal cancer cell lines. A study of Asian ginseng in mice observed that it prevented tumor spread to the lungs and the formation of new blood vessels (angiogenesis).
A 2006 observational study found better quality of life and somewhat longer survival in breast cancer patients using ginseng, but ignored type and dose. A clinical study of 40 healthy participants suggested protection of lymph cells against radiation.
Does It Help Cancer-Related Fatigue?
Fatigue is among the most common, most distressing and most physically limiting complaints in cancer patients. Statistics show fatigue in %59 to %96 of patients receiving chemotherapy and %65 to %100 of those receiving radiotherapy, with complaints continuing for an average of 5-10 years after diagnosis. Certain inflammatory processes and inadequate control of blood cortisol are held responsible for fatigue in cancer patients. Laboratory studies have shown anti-inflammatory and cortisol-regulating effects of ginseng, suggesting it could help cancer-related fatigue. A comprehensive study conducted by Mayo Clinic Cancer Center, a leading oncology organization, presented at the 2012 ASCO (American Society of Clinical Oncology) meeting, showed that high-dose (2000 mg/gün) American ginseng benefited cancer-related fatigue. From 40 separate institutions, 364 cancer patients participated in the study testing capsules obtained from pure American ginseng roots. After 8 weeks, cancer-related fatigue improved on the standard fatigue scale of 100 points by 20 points. Those actively receiving cancer treatment benefited more than those who had completed treatment. No significant difference in side effects was observed. The study specifically used pure ginseng; it noted that commercially sold products acquire estrogen-like properties during processing with alcohol and may harm breast cancer patients. Given the limited effective treatments available for cancer-related fatigue, the study concluded that American ginseng could be tried. In a study testing Asian ginseng for cancer-related fatigue, 30 patients received high-dose Asian ginseng for 29 days (800 mg/gün), resulting in a marked reduction in fatigue without a difference in side effects. Given Asian ginseng's similarity to American ginseng, it is likely to be effective in this regard. However, this was a preliminary report and needs support from further studies.
What Are the Possible Side Effects and Risks?
American ginseng is in category 1 of the American Herbal Products Association's safety rating, meaning it is generally considered safe when used appropriately. A study assessing dose-related side effects divided 290 people into groups taking daily doses of 750 mg, 1000 mg, 2000 mg or no ginseng. No significant difference in side effects between groups was observed during follow-up. Nevertheless, many adverse effects, particularly drug interactions, have been reported in the literature. Reported effects include nausea, diarrhea, headache, nosebleeds, high blood pressure, low blood pressure and breast pain.
Studies have established that ginseng products processed with alcohol can have estrogen-like effects. It has therefore been emphasized that people who need to avoid estrogen should not use ginseng (36, 37, 38). A laboratory study also found that ginseng stimulated cell growth in breast cancer cell lines.
Drug interactions are the most important concern about ginseng use. Ginsenosides, ginseng's active components, are held responsible. Studies have shown that ginsenosides interact with the drug group called monoamine oxidase inhibitors. There is also a study of interaction with nifedipine. It can interact with warfarin (Coumadin), causing bleeding disorders; with imatinib, causing liver damage; and with antidepressants, causing the onset of mania. A clinical study in 20 healthy people also showed that American ginseng reduced warfarin's anticoagulant effect, emphasizing that physicians should ask patients about ginseng use when prescribing warfarin.
What Should Be Done?
In conclusion, ginseng is an herbal product claimed to be effective in preventing and treating many health problems. However, studies have not demonstrated many of these effects. Research on colds, diabetes, Alzheimer's disease and erectile dysfunction is promising but remains insufficient for clinical application. Studies of cancer prevention and treatment are primarily laboratory experiments and are extremely limited. More research is needed to clarify ginseng's role in cancer, appropriate dose, side effects and drug interactions. The only clear benefit demonstrated in cancer patients to date is reduced cancer-related fatigue. Given the limited treatment options, considering ginseng for this purpose may be reasonable. However, great caution is needed regarding drug interactions. Certain commercial forms have been reported to cause harm in breast cancer patients through estrogen-like effects. It is therefore extremely important that physicians understand these interactions and monitor patients closely, and that patients consume no health-related products without their physicians' knowledge and supervision.
*
- Herbal Treatment, Phytotherapy and Cancer Prevention - Dream or Reality?
Sources
2) Stavro PM, Woo M, Heim TF, Leiter LA, Vuksan V. North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension. Hypertension. 2005; 46:406-11.
3) Oxford Dictionaries Online, s.v. "ginseng". https://www.oxforddictionaries.com/definition/english/ginseng
4) Li B, Wang CZ, He TC, Yuan CS, Du W. Antioxidants potentiate American ginseng-induced killing of colorectal cancer cells. Cancer Lett. 2010; 289:62–70.
5) Jang DJ, Lee MS, Shin BC, Lee YC, Ernst E. Red ginseng for treating erectile dysfunction: a systematic review. Br J Clin Pharmacol. 2008; 66:444-50.
6) Wang X, Sakuma T, Asafu-Adjaye E, Shiu GK. Determination of ginsenosides in plant extracts from Panex ginseng and Panex quinquefolius L. by LC/MS/MS. Anal Chem. 1999; 71:1579–1584.
7) Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999; 58:1685–1693.
8) Yap KY, Chan SY, Weng Chan Y, Sing Lim C. Overview on the analytical tools for quality control of natural product-based supplements: a case study ofginseng. Assay Drug Dev Technol. 2005; 3:683-99.
9) Clauson KA, Shields KM, McQueen CE, Persad N. Safety issues associated with commercially available energy drinks. J Am Pharm Assoc. 2008; 48:55–63.
10) Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med. 2002; 136:42-53.
11) Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004; 22:2489-503.
12) Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000; 160:1009-13.
13) Mucalo I, Jovanovski E, Vuksan V, Božikov V, Romić Z, Rahelić D. American Ginseng Extract (Panax quinquefolius L.) Is Safe in Long-Term Use in Type 2 Diabetic Patients. Evid Based Complement Alternat Med. 2014; 2014:969168.
14) Predy GN, Goel V, Lovlin R, Donner A, Stitt L, Basu TK. Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial. CMAJ. 2005; 173:1043-8.
15) Scholey A, Ossoukhova A, Owen L, Ibarra A, Pipingas A, He K, Roller M, Stough C. Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl). 2010; 212:345-56.
16) Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008; 22:222–226.
17) U.S. National Institutes of Health, National Library of Medicine, Drugs, Herbs and Supplements; Ginseng, Panax. https://www.nlm.nih.gov/medlineplus/druginfo/natural/1000.html
18) Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013; 105:1230-8.
19) Li XL, Wang CZ, Sun S, Mehendale SR, Du W, He TC, Yuan CS. American ginseng berry enhances chemopreventive effect of 5-FU on human colorectal cancer cells. Oncol Rep. 2009; 22:943-52.
20) King ML, Murphy LL. American ginseng (Panex quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells. J Exp Ther Oncol. 2007; 6:147–155.
21) Duda RB, Zhong Y, Navas V, Duda RB, Zhong Y, Navas V, Li MZ, Toy BR, Alavarez JG. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol. 1999; 72:230–239.
22) M. Mochizuki, Y.C. Yoo, K. Matsuzawa, K. Sato, I. Saiki, S. Tono-Oka, K.I. Samukawa, I. Azuma. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, ofRed ginseng. Biol Pharm Bull. 1995; 18:1197–1202.
23) Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J. Brief Communication: American Ginseng reduces Warfarin’s effect in healthy patients. Annals of Internal Medicine. 2004; 141:23-27.
24) Cui Y, Shu XO, Gao YT, Cai H, Tao MH, Zheng W. Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 2006; 163:645-53.
25) Lee TK, O'Brien KF, Wang W, Johnke RM, Sheng C, Benhabib SM, Wang T, Allison RR. Radioprotective effect of American ginseng on human lymphocytes at 90 minutes postirradiation: a study of 40 cases. J Altern Complement Med. 2010; 16:561-7.
26) Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007; 12:4–10.
27) Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors—a systematic review. Int J Pych Med. 2010; 40:163–181.
28) Jin Y, Hofseth AB, Cui X, Windust AJ, Poudyal D, Chumanevich AA, Matesic LE, Singh NP, Nagarkatti M, Nagarkatti PS, Hofseth LJ. American ginseng suppresses colitis through p53-mediated apoptosis of inflammatory cells. Cancer Prev Res (Phila). 2010; 3:339–347.
29) Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, Dai C, Zhao Q, Wu X, Xie L, Wang G. Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation. 2011; 8:100.
30) Yang CS, Ko SR, Cho BG, Shin DM, Yuk JM, Li S, Kim JM, Evans RM, Jung JS, Song DK, Jo EK. The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock. J Cell Mol Med. 2008; 12:1739–1753.
31) Yennurajalingam S, Reddy A, Tannir NM, Chisholm GB, Lee RT, Lopez G, Escalante CP, Manzullo EF, Frisbee Hume S, Williams JL, Cohen L, Bruera E. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. Integr Cancer Ther. 2015; 14:419-27.
32) Blumenthal M, Brinckmann JA, Wollschlaeger B. The ABC Clinical Guide to Herbs. Austin, TX, American Botanical Council, 2003.
33) Barton DL, Soori GS, Bauer BA, Sloan JA, Johnson PA, Figueras C, Duane S, Mattar B, Liu H, Atherton PJ, Christensen B, Loprinzi CL. Pilot study of Panex quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2010; 18:179–187.
34) "Ginseng definition - Medical Dictionary definitions of some medical terms defined on MedTerms. 2012. https://www.medicinenet.com/script/main/art.asp?articlekey=17671
35) Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician. 2003; 68:1539–42.
36) Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab. 2002; 87:3691–5.
37) Lee YJ, Jin YR, Lim WC, Park WK, Cho JY, Jang S, Lee SK. Ginsenoside-Rb1 acts as a weak phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res. 2003; 26:58–63.
38) Lee Y, Jin Y, Lim W, Ji S, Choi S, Jang S, Lee S. A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J Steroid Biochem Mol Biol. 2003; 84:463–8.
39) Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause. 2002; 9:145-50.
40) Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs. 2001; 61:2163–75.
41) Smith M, Lin KM, Zheng YP. An open trial of nifedipine-herb interactions: Nifedipine with St. John’s wort, ginseng or Ginkgo biloba. Clin Pharmacol Ther. 2001; 69:86.
42) Fugh-Berman A. Herb-drug interactions. Lancet. 2000; 355:134–8.
43) Bilgi N, Bell K, Ananthakrishnan AN, Atallah E. Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity. The Annals of Pharmacotherapy. 2010; 44:926–8.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.